Valbenazine is a medication being studied to see if it can help people with schizophrenia who are not getting enough relief from their current antipsychotic treatments. Schizophrenia is a mental health condition that can cause symptoms like hallucinations, delusions, and trouble thinking clearly. Valbenazine is thought to work by affecting certain chemicals in the brain that may be involved in these symptoms. In this trial, researchers are looking at how well valbenazine can improve these symptoms when added to the treatment that patients are already receiving.

Schizophrenia – Schizophrenia is a chronic mental disorder characterized by disruptions in thought processes, perceptions, emotional responsiveness, and social interactions. It typically manifests with symptoms such as hallucinations, delusions, disorganized thinking, and significant impairments in daily functioning. The progression of schizophrenia can vary, with some individuals experiencing episodes of acute symptoms followed by periods of remission, while others may have a more continuous course. Over time, the disorder can lead to difficulties in maintaining personal relationships and employment. Cognitive impairments, such as problems with memory and attention, are also common and can worsen as the disease progresses. Social withdrawal and reduced motivation are often observed, impacting the individual’s ability to engage in everyday activities.